Abiopharma

News list

Director Heard William 🔴 sold 1.9K shares of Anterix Inc. (ATEX) Transaction Date: Dec 29, 2025 | Filing ID: 000004

Full text

News bot Aug. 7, 2026, 10:32 p.m.
🔍 Heard William (Director)

Company: Anterix Inc. (ATEX)

Report Date: 2025-12-29
Transaction Summary:
- Total transactions: 2
- Derivative instruments: 0
- Holdings reported: 1
- Total shares sold: 1,887
- Total shares held: 1,716,738
Detailed Transactions and Holdings:
- Sold 1,887 shares of Common Stock, par value $0.0001 per share ("Common Stock") (Direct)
  Date: 2025-12-29 | Code: G | equity_swap_involved: 0 | shares_owned_after: 9,365.00 | transaction_form_type: 4 | Footnotes: F1
- Holds 0 shares of Common Stock (Direct)
  Date: 2025-12-29 | Code: H | nature_of_ownership: By Heard Capital LLC | shares_owned_after: 1,716,738.00 | Footnotes: F2
Footnotes:
- F1: Represents a charitable donation of shares to a Donor Advised Fund.
- F2: These securities are held by certain investment funds and/or accounts for which Heard Capital LLC serves as investment manager. The Reporting Person is the ultimate beneficial owner of Heard Capital LLC. Each of Heard Capital LLC and the Reporting Person disclaims beneficial ownership of the securities to which this filing relates for purposes of Section 16 of the Securities and Exchange Act of 1934, as amended, except to the extent of his or its pecuniary interest therein.